[1]黄子恩,张 炜,耿 耘,等.寨卡病毒疫苗的研究进展[J].中国预防兽医学报,2018,(05):459-462.[doi:10.3969/j.issn.1008-0589.201704015]
点击复制

寨卡病毒疫苗的研究进展()
分享到:

《中国预防兽医学报》[ISSN:1008-0589/CN:23-1417/S]

卷:
期数:
2018年05
页码:
459-462
栏目:
综述
出版日期:
2018-05-15

文章信息/Info

文章编号:
1008-0589(2018)5-0459-04
作者:
 

黄子恩1张 炜2耿 耘1雷 涵2*

 (1. 西南交通大学 生命科学与工程学院,四川 成都 610031;2. 西南交通大学 医学院,四川 成都 610031)
分类号:
S852.65
DOI:
10.3969/j.issn.1008-0589.201704015
文献标志码:
B

参考文献/References:

[1]Dick G W, Kitchen S F, Haddow A J. Zika virus. I. Isolations and serological specificity [J]. Trans R Soc Trop Med Hyg, 1952, 46(5): 509-520.
[2]Duffy M R, Chen T H, Hancock W T, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia [J]. N Engl J Med, 2009, 360(24): 2536-2543.
[3]Aubry M, Teissier A, Huart M, et al. Zika virus seroprevalence, French Polynesia, 2014-2015 [J]. Emerg Infect Dis, 2017, 23(4): 669-672.
[4]Bogoch I, Brady O J, Kraemer M U, et al. Anticipating the international spread of Zika virus from Brazil [J]. Lancet, 2016, 387(10016): 335-336.
[5]Li Jian-dong, Xiong Ying, Wu Wei, et al. Zika virus in a traveler returning to China from caracas, venezuela, february 2016 [J]. Emerg Infect Dis, 2016, 22(6): 1133-1136.
[6] Gyawali N, Bradbury R S, Taylor-Robinson A W. The global spread of Zika virus: is public and media concern justified in regions currently unaffected? [J]. Infect Dis Poverty, 2016, 5: 37.
[7]Baronti C, Piorkowski G, Charrel R N, et al. Complete coding sequence of Zika virus from a French polynesia outbreak in 2013 [J]. Genome Announc, 2014, 2(3): e00500-14.
[8]Sirohi D, Chen Zhen-guo, Sun Lei, et al. The 3.8 A resolution cryo-EM structure of Zika virus [J]. Science, 2016, 352(6284): 467-470.
[9]Kostyuchenko V A, Lim E X, Zhang Shui-jun, et al. Structure of the thermally stable Zika virus [J]. Nature, 2016, 533(7603): 425-428.
[10]Larocca R A, Abbink P, Peron J P, et al. Vaccine protection against Zika virus from Brazil [J]. Nature, 2016, 536(7617): 474-478.
[11]Dowd K A, Ko S Y, Morabito K M, et al. Rapid development of a DNA vaccine for Zika virus [J]. Science, 2016, 354(6309): 237-240.
[12]Abbink P, Larocca R A, De La Barrera R A, et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys [J]. Science, 2016, 353(6304): 1129-1132.
[13]Muthumani K, Griffin B D, Agarwal S, et al. In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv []DNA vaccine [J]. Vaccines, 2016, 1(1): 16021.
[14]Petersen L R, Jamieson D J, Powers A M, et al. Zika virus [J]. N Engl J Med, 2016, 374(16): 1552-1563.
[15]Pardi N, Hogan M J, Pelc R S, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination [J]. Nature, 2017, 543(7644): 248-251.
[16]Richner J M, Himansu S, Dowd K A, et al. Modified mRNA vaccines protect against Zika virus infection [J]. Cell, 2017, 168(6): 1114-1125.
[]Shan Chao, Muruato A E, Nunes B T D, et al. A live-attenuated Zika virus vaccine 17candidate induces sterilizing immunity in mouse models [J]. Nat Med, 2017, 23(6): 763-767.
[18]Barouch D H, Thomas S J, Michael N L. Prospects for a Zika virus vaccine [J]. Immunity, 2017, 46(2): 176-182.
[19]Kim E, Erdos G, Huang Shao-hua, et al. Preventative vaccines for Zika virus outbreak: preliminary evaluation [J]. EBio Medicine, 2016, 13: 315-320.
[20]Xie Xu-ping, Yang Yu-jiao, Muruato A E, et al. Understanding Zika virus stability and developing a chimeric vaccine through functional analysis [J]. MBio, 2017, 8(1): e02134-16.
[21]Russell P K, Udomsakdi S, Halstead S B. Antibody response in dengue and dengue hemorrhagic fever [J]. Jpn J Med Sci Biol, 1967, 20 Suppl: 103-108.
[22]Burke D S, Nisalak A, Johnson D E, et al. A prospective study of dengue infections in Bangkok [J]. Am J Trop Med Hyg, 1988, 38(1): 172-180.
[23]Dejnirattisai W, Supasa P, Wongwiwat W, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus [J]. Nat Immunol, 2016, 17(9): 1102-1108.
[24]Kawiecki A B, Christofferson R C. Zika virus-induced antibody response enhances dengue virus serotype 2 replication in vitro [J]. J Infect Dis, 2016, 214(9): 1357-1360.
[25]Bardina S V, Bunduc P, Tripathi S, et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity [J]. Science, 2017, 356(6334): 175-180.
[26]Schuler-Faccini L, Ribeiro E M, Feitosa I M, et al. Possible association between Zika virus infection and microcephaly - Brazil, 2015 [J]. MMWR Morb Mortal Wkly Rep, 2016, 65(3): 59-62.
[27]Li Cui, Xu Dan, Ye Qing, et al. Zika virus disrupts neural progenitor development and leads to microcephaly in mice [J]. Cell Stem Cell, 2016, 19(1): 120-126.
[28]Atkinson B, Hearn P, Afrough B, et al. Detection of Zika virus in semen [J]. Emerg Infect Dis, 2016, 22(5): 940.
                     (本文编辑:李 娜)

更新日期/Last Update: 2018-05-16